imatge entitat
Societat Catalana d'Immunologia 
XIVth Congress Catalan Society of Immunology (SCI). Joint meeting with European Federation of Immunological Societies on Tour (EFIS on TOUR)

Dies 19 i 20 de novembre de 2020 | Online

19-11-2020 | Online | Online (Online)

15:30 - 16:00 Arrival, Registration and Documentation delivery

16:00 - 16:15 Welcome to the XIVth CONGRESS of the SCI

Presentador/a: Dr. Marcos López Hoyos  

President of the SEI

Presentador/a: Dr. Ricardo Pujol Borrell  

President of the SCI

16:15 - 17:00 Opening Lecture –

Immunological memory against the dogma

Ponent: Dr. Andreas Radbruch

Charité, Universitätsmedizin Berlin

Moderador/a: Dr. Pablo Engel Rocamora

University of Barcelona

17:00 - 17:30 Poster viewing

17:30 - 18:00 Plenary Session: Inter-TCR crosstalk during antigen recognition.

Ponent: Dr. Balbino Alarcón  

Centro Biología Molecular Severo Ochoa, Madrid

Moderador/a: Dra. Annabel Valledor  

University of Barcelona

18:00 - 19:45 Oral Communications, Session-1 – Basic and Experimental Immunology

Moderador/a: Dr. Winfried Pickl  

Medical University of Vienna

Experimental and genetic evidence for the involvement of CD6 in inflammatory bowel diseases.

Ponent: Dr. Sergi Casadó Llombar

et al.

Macrophage mitochondrial MFN2 (mitofusin 2) links immune stress and immune response through reactive oxygen species (ROS) production

Ponent: Dr. Antonio Celada

et al.

Immunomodulation of type 1 diabetes by 116C-NOD intestinal microbiota

Ponent: Dra. Estela Rosell Mases

et al.

siRNA-containing transfection of vitamin D3-induced tolerogenic dendriticcells for the silencing of potential tolerogenic genes

Ponent: Dr. Íñigo González Larreategui

et al.

Immunomodulatory properties of a soluble cytomegalovirus-encoded CD48 Homolog.

Ponent: Dr. Francesc Poblador

et al.

MRL mice infected with cytomegalovirus (CMV) as an animal model of Sjögren’s Syndrome.

Ponent: Dr. Joan Puñet Ortiz

et al.

HIV-1 enveloped Virus-Like Particles (VLP) displaying high density of HIV-1 Env-derived antigens on their surface induce a functional immune response beyond neutralizing activity

Ponent: Dr. Ferran Tarrés Freixas

et al.

19:25 - 19:45 Discussion (Oral Communications, Session-1 – Basic and Experimental Immunology)

19:45 - 20:15 Plenary Session: The role of a new T helper cell type, Th-IL-2 cells, in allergic immune reactions

Moderador/a: Dra. Eva Maria Martinez Carceres  

Autonomus University of Barcelona

Ponent: Dr. Winfried Pickl  

Medical University of Vienna

20-11-2020 | Online | Online (Online)

08:30 - 09:00 Arrival, Registration and Documentation delivery

09:00 - 09:30 Plenary Session: Tissue memory cells at the center of the immune system

Ponent: Dr. René Van Lier  

Sanquin Blood Supply. University of Amsterdam

Moderador/a: Dra. Dolores Jaraquemada Perez de Guzmán  

Autonomous University of Barcelona

09:30 - 10:00 Plenary Session: Development of humen “adaptive” NK cell populations: open issues.

Moderador/a: Dr. Miguel López Botet  

University Pompeu Fabra, Barcelona

Moderador/a: Dr. Pablo Engel Rocamora  

University of Barcelona

10:00 - 11:30 Oral Communications, Session 2: Clinical Immunology I

Moderador/a: Dra. Cristina Costa Vallès  

(IDIBELL, Barcelona

Moderador/a: Dra. Mª Rosa Faner Canet  

Hospital Clinic, Barcelona

Changes induced in lymphocyte subpopulations by dimethyl-fumarate treatment in multiple sclerosis could identify “NEDA” patients.

Ponent: Dra. Aina Teniente Serra

et al.

Lymphocyte subpopulations analysis in psoriatic patients treated with biological drugs

Ponent: Dr. Marc Boigues Pons

et al.

Myeloid-Derived Suppressor Cells in Kidney Transplant Recipients and the effect of Maintenance Immunotherapy

Ponent: Dra. María Iglesias Escudero

et al.

Pretransplant adaptive NKG2C+ NK cells protect against cytomegalovirus infection in kidney transplant recipients

Ponent: Dra. Michelle Ataya

et al.

Impaired lung NK activity in the lung of Idiopathic Pulmonary Fibrosis patients

Ponent: Dra. Tamara Cruz

et al.

Immunophenotype in CU patients under omalizumab treatment.

Ponent: Dra. Cristina Alejandra López Rodriguez

11:30 - 12:00 Plenary Session: Conventional and unconventional T cell response to microbial antigens.

Ponent: Dra. Federica Sallusto  

Institute for Research in Biomedicine Bellinzona

Moderador/a: Dr. Ricardo Pujol Borrell  

Autonomous University of Barcelona

12:00 - 13:00 Ordinary General Meeting- Societat Catalana d’Immunologia

13:00 - 13:30 Poster viewing

13:30 - 14:00 Lunch session sponsored by Becton Dickinson.Resolving immune cell identity one cell at time. The multiomic approach.

Ponent: Dr. Werner Rodriguez  

BD Biosciences | Single Cell Multiomics

14:30 - 16:15 Oral Communications, Session 3: Tumor Immunology and Immunotherapy

Moderador/a: Dr. Manel Juan Otero  

Hospital Clinic. Barcelona

Phase I multicenter clinical trial with chimeric antigen receptor with humanized anti-BCMA specific ( ARI0002h) in patients with relapsed or refractory multiple myeloma

Ponent: Dra. Mariona Pascal Capdevila

et al.

CART19-BE-01: un ensayo académico Europeo sobre la administración de células CAR-T denominadas ARI-0001 en pacientes con trastornos linfoproliferativos CD19+.

Ponent: Dr. Valentín Ortiz Maldonado

et al.

Humoral immune response in patients with CD19 positive relapsed/refractory B-cell malignances recruited into the CART19-BE-01 clinical trial

Ponent: Dra. Ariadna Bartoló Ibars

et al.

Comparative analysis and characterization of TCR repertoires in breast cancer TILs

Ponent: Dra. Andrea Aran Garriga

et al.

HAVCR2 mutations altering TIM-3 underlying hemophagocytic syndrome and subcutaneous panniculitis-like T-cell lymphoma.

Ponent: Dr. Roger Colobran Oriol

et al.

Dynamics of T-cell subsets in non-small cell lung cancer patients treated with PD-1/PD-L1 axis blocking mAbs

Ponent: Dra. Coral Zurera Egea

et al.

NK cell receptors and ligand variants modulate response to tyrosine kinaseinhibitors in patients with chronic myeloid leukemia

Ponent: Dra. Laia Closa Gil

et al.

15:55 - 16:15 Discussion (Oral Communications, Session 3: Tumor Immunology and Immunotherapy)

16:15 - 16:45 Plenary Session: Unconventional receptor-based antibodies

Moderador/a: Dr. Miguel López Botet  

(University Pompeu Fabra , Barcelona

Ponent: Dr. Antonio Lanzavecchia  

National Institute of Molecular Genetics, Milan

16:45 - 18:00 Oral Communications, Session 4: COVID-19

Moderador/a: Dra. Silvia Vidal Alcorisa  

Santa Creu i Sant Pau Hospital, Barcelona

Early S2-targeting and rapid development of neutralizing antibodies after SARS-CoV-2 infection.

Moderador/a: Dra. Maria Luisa Rodriguez de la Concepción

et al.

Antigen-specific lymphocyte proliferation against SARS-CoV-2 in COVID patients with negative antibodies against the virus in serum

Ponent: Dra. Marc Boigues Pons

et al.

Immunological Risk Profile in COVID-19, the Experience of a Single Academic Hospital in Catalonia.

Ponent: Dr. Manuel Hernández González

et al.

Immunopathogenesis of COVID-19-related pediatric inflammatory multisystem syndrome: overlap with Kawasaki disease and identification of a distinct severe group

Ponent: Dra. Ana Esteve Solé

et al.

Revealing protective T cell immune responses against SARS-CoV-2.

Ponent: Dra. Judith Grau Expósito

et al.

Inborn errors and autoantibodies against type-I inteferons in patients with life-threatening COVID-19.

Ponent: Dr. Roger Colobran Oriol

et al.

17:45 - 18:00 Discussion.(Oral Communications, Session 4: COVID-19)

18:00 - 18:15 Prize to the best communication and poster

Ponent: Dr. Ricardo Pujol Borrell  

(President of SCI

18:15 - 18:30 Closing of the Congress

Presentador/a: Dr. Ricardo Pujol Borrell  

(President of SCI